LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples

Authors:

Abstract
Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2–3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.
Funding Information
  • Jane Coffin Childs Memorial Fund for Medical Research (NIGMS F32GM142146-01)
  • National Institute of General Medical Sciences (NIGMS F32GM140637-01)
  • NIH NRSA F31 Pre-doctoral Fellowship (NHLBI, 1F31HL156468-01)
  • Cancer Research Institute
  • National Science Foundation (DGE175814)
  • National Institute on Aging (1F99AG068343-01)
  • Shurl and Kay Curci Foundation
  • David and Lucile Packard Foundation
  • Greater Good Science Center and the UC Berkeley Stem Cell Center (NIH T32GM139780)

This publication has 18 references indexed in Scilit: